GenenDesign Co., Ltd

GenenDesign Co., Ltd was founded in 2007 with a vision to establish the largest cancer model platform for research, drug discovery, and patient treatment. The company's dedication to advancing cancer treatment is evident through its focus on developing more effective and affordable cancer drugs. With locations in Shanghai, China, and Menlo Park, California, USA, GenenDesign values cutting-edge science and technology for the betterment of cancer patients. The belief in finding drug treatments tailored for each cancer patient is central to its mission. The company anticipates a transformation in the health care industry, shifting from "developing drugs" to "choosing drugs" within the next decade. GenenDesign's commitment to precision, persistence, and the pursuit of cures positions it as a significant player in the biotechnology and health care sectors.